Kezar Life Sciences Financial Overview
Kezar Life Sciences's market cap is currently $45.77M. The company's EPS TTM is $-1.53; its P/E ratio is -0.74; Kezar Life Sciences is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-1.49. See an overview of income statement, balance sheet, and cash flow financials.
